TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Government & Organizations

    This Week in Cardiology

    This podcast delivers Dr. John Mandrola’s summary and perspective on top news of the week that cardiologists can’t miss. This podcast is intended for US health professionals only.

    Advertise

    Copyright: © Copyright 2019, Medscape

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Aug 18 2023 This Week in Cardiology Aug 18, 2023
    Show notes

    ICD generator change, less is more in VT management, co-morbidity in HF, and SGLT2i after AF ablation are the topics discussed by John Mandrola, MD, in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I. ICD Gen Change

    - Patients' Perspectives Regarding Generator Exchanges of Implantable Cardioverter Defibrillators https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.122.009827

    - DEFINITE https://www.nejm.org/doi/10.1056/nejmoa033088

    - SCD-HeFT https://www.nejm.org/doi/full/10.1056/nejmoa043399

    - DANISH https://www.nejm.org/doi/10.1056/NEJMoa1608029

    - Poole and colleagues; 11-year follow-up of SCD-HeFT https://doi.org/10.1016/j.jacc.2020.05.061

    - Editorial – Howell/Stecker https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.123.010266

    II. VT Therapy

    Crossed Wires: Ischemia Testing and Monomorphic VT Storm

    https://www.medscape.com/viewarticle/995401

    - Cleveland Clinic Study

    https://doi.org/10.1016/j.jacep.2023.04.030

    III. Co-Morbidity in HF

    - Hospital admissions in the last year of life of patients with heart failure

    https://doi.org/10.1093/ehjqcco/qcad047

    - Four Horsemen of Apocalypse Lecture

    http://www.louisvillelectures.org/imblog/2017/10/5/whw8sf0m1k0wi6lm6kvjsx4nxzzjg5

    IV. SGLT2i After Ablation for AF

    SGLT2 Inhibitors Curb AF Post-Ablation Recurrences in Diabetes

    https://www.medscape.com/viewarticle/995415

    - Observational Study – Abu-Qaoud et al

    https://www.jacc.org/doi/full/10.1016/j.jacep.2023.06.008

    - Meta-analysis SGLT2i and AF

    https://www.ahajournals.org/doi/full/10.1161/JAHA.121.022222

    You may also like:

    Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

    https://www.medscape.com/features/public/machine

    The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

    https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Aug 11, 2023 This Week in Cardiology Podcast Aug 11, 2023
    Show notes

    Observational studies, another defense of digoxin, CTO-PCI, BP measurement, and a possible revolution in cardiovascular protection are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I. Observational Research

    Yeh; Credibility in Observational Research https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.064645

    Hernan; Causal Language in Observational Research https://ajph.aphapublications.org/doi/full/10.2105/AJPH.2018.304337

    Wang; RCT Duplicate Initiative https://jamanetwork.com/journals/jama/fullarticle/2804067

    II. Defense of Digoxin

    Brophy; Beta Blockers, Digoxin, or Both https://doi.org/10.1016/j.cjca.2023.06.009

    Dorian editorial https://doi.org/10.1016/j.cjca.2023.07.013

    Ziff Digoxin Meta-analysis https://www.bmj.com/content/351/bmj.h4451.long

    DIG trial https://www.nejm.org/doi/full/10.1056/nejm199702203360801

    Davila Analysis of DIG Trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801940/

    Kotecha Meta-analysis of Beta Blockers https://pubmed.ncbi.nlm.nih.gov/25193873/

    RATE-AF https://jamanetwork.com/journals/jama/fullarticle/2774407

    III. CTO-PCI

    PCI of Chronic Total Occlusions Improves Angina, Quality of Life in Trials https://www.medscape.com/viewarticle/994739

    JAMA Network Open Meta-analysis

    IV. BP Measurement

    One Size Doesn't Fit All in Blood Pressure Measurement https://www.medscape.com/viewarticle/995216

    Ishigami Blood Pressure Measurement Comparison

    https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2807853

    V. GLP-1 SELECT Trial

    Semaglutide Cuts Cardiovascular Events in Landmark Trial

    https://www.medscape.com/viewarticle/995270

    SELECT Protocol Paper

    You may also like:

    Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

    https://www.medscape.com/features/public/machine

    The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

    https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Aug 04 2023 This Week in Cardiology Aug 04, 2023
    Show notes

    Listener feedback re observational studies, surgeons' dissent from recent guidelines, aspirin for primary prevention, and fish oil are the topics discussed by John Mandrola.MD in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I. Heart Surgeons Dissent

    Surgical Groups Push Back Against New Revascularization Guidelines

    https://www.medscape.com/viewarticle/966153

    New Revascularization Guidelines: Key Points and Navigating Controversies

    https://www.medscape.com/viewarticle/972014

    - AHA Guidelines - https://doi.org/10.1161/CIR.0000000000001168

    - AATS statement 2023 https://doi.org/10.1016/j.jtcvs.2023.03.001

    - Yusef and colleagues 1994 Meta-analysis - https://doi.org/10.1016/S0140-6736(94)91963-1

    - 10-year SYNTAXES https://doi.org/10.1016/S0140-6736(19)31997-X

    - Surgeons' argument 2021 https://doi.org/10.1016/j.athoracsur.2021.12.003

    - FAME 3 https://www.nejm.org/doi/full/10.1056/NEJMoa2112299

    - Gaudino Meta-analysis of Medical Therapy vs CABG https://doi.org/10.1016/j.jtcvs.2022.06.003

    - NOBLE https://doi.org/10.1016/S0140-6736(19)32972-1

    - EXCEL 5 years https://www.nejm.org/doi/full/10.1056/nejmoa1909406

    II. ASA for Primary Prevention

    Daily Aspirin Challenged in Primary Stroke Prevention: ASPREE

    https://www.medscape.com/viewarticle/994963

    - ASPREE – All-cause mortality

    - ASPREE (MACE and Bleeding) https://www.nejm.org/doi/full/10.1056/NEJMoa1805819

    - ASPREE (disability) https://www.nejm.org/doi/full/10.1056/NEJMoa1800722

    - JAMA Network Open Subanalysis https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807630

    III. Fish Oil

    - OMEMI Substudy https://doi.org/10.1016/j.clnu.2023.07.002

    - Gencer and colleagues Meta-analysis - https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055654

    - OMEMI Main Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.052209

    You may also like:

    Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

    https://www.medscape.com/features/public/machine

    The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

    https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Jul 28 2023 This Week in Cardiology Jul 28, 2023
    Show notes

    Antiarrhythmic drugs in patients with CAD, observational studies, GLP-1 agonists, and the subcutaneous ICD are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I. AAD in Patients with CAD

    - The Feasibility and Safety of Flecainide Use Among Patients With Varying Degrees of Coronary Disease

    https://doi.org/10.1016/j.jacep.2022.12.021

    - Three Questions for Evidence-Based Cardiac Electrophysiology

    https://www.ahajournals.org/doi/full/10.1161/circoutcomes.110.957381

    - The Cardiac Arrhythmia Suppression Trial (CAST) https://www.nejm.org/doi/full/10.1056/nejm198908103210608

    II. GLP-1 Agonists

    Tirzepatide Powers Weight Loss in Two More Pivotal Trials https://www.medscape.com/viewarticle/994889

    Semaglutide Use Surges in US Adults With Type 2 Diabetes https://www.medscape.com/viewarticle/994873

    - Tirzepatide Once Weekly for the Treatment of Obesity

    https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

    - Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

    https://doi.org/10.1016/S0140-6736(23)01200-X

    III. S-ICD

    S-ICD Shows Virtues, Limits in 'Real World' Postmarket Study https://www.medscape.com/viewarticle/994851

    - Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System https://doi.org/10.1016/j.jacc.2023.05.034

    - Subcutaneous or Transvenous Defibrillator Therapy https://www.nejm.org/doi/full/10.1056/NEJMoa1915932

    - Letter to the Editor https://www.nejm.org/doi/full/10.1056/NEJMc2034917

    You may also like:

    Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

    https://www.medscape.com/features/public/machine

    The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

    https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Jul 21 2023 This Week in Cardiology Jul 21, 2023
    Show notes

    Listener feedback, conduction system pacing, eating fish vs fish pills, exercise, and an RCT for diet are the topics discussed by John Mandrola,.MD, in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I. Listener Feedback Monitor HF and AHA

    Jun 02, 2023 This Week in Cardiology Podcast

    https://www.medscape.com/viewarticle/992678

    - Link to the ACC Email -- https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/07/18/17/21/monitor-hf

    - Tweet From Anthony Pearson

    https://twitter.com/skepcard/status/1681288604990189574

    II. Conduction System Pacing

    - Clinical Outcomes in Conduction System Pacing Compared to Right Ventricular Pacing in Bradycardia https://doi.org/10.1016/j.jacep.2022.10.016

    - Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women https://www.acpjournals.org/doi/abs/10.7326/0003-4819-117-12-1016

    III. Fish Oil

    Omega-3s and AF: No Added Risk From Eating Fish but High-Dose Supplement Questions Persist https://www.medscape.com/viewarticle/994559

    - Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation

    https://www.jacc.org/doi/full/10.1016/j.jacc.2023.05.024

    - Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia https://www.nejm.org/doi/full/10.1056/nejmoa1812792

    - Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055654

    IV. Exercise

    Even Exercise by 'Weekend Warriors' Can Cut CV Risk

    https://www.medscape.com/viewarticle/994617

    - Accelerometer-Derived "Weekend Warrior" Physical Activity and Incident Cardiovascular Disease https://jamanetwork.com/journals/jama/article-abstract/2807286

    V. Diet

    Cognitive Benefit of Highly Touted MIND Diet Questioned

    https://www.medscape.com/viewarticle/994550

    - Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons

    https://www.nejm.org/doi/full/10.1056/NEJMoa2302368

    You may also like:

    Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

    https://www.medscape.com/features/public/machine

    The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

    https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact

    news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    July 14 2023 This Week in Cardiology Jul 14, 2023
    Show notes

    Carotid stents, the paclitaxel story now closed, inclisiran, DOAC failures, and primary vs secondary prevention are the topics John Mandrola, MD, covers in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I. Carotid Stenting CMS Proposal

    Expanded Coverage of Carotid Stenting in CMS Draft Proposal

    https://www.medscape.com/viewarticle/994315

    No Added Benefit From Revascularization in Low-Risk CAS

    https://www.medscape.com/viewarticle/992524

    - Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=Y&NCAId=311

    - Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

    https://doi.org/10.1016/S0140-6736(21)01910-3

    - SPACE-2 https://journals.sagepub.com/doi/10.1177/1747493019833017

    - Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial 10.1161/STROKEAHA.120.030730

    II. Paclitaxel

    FDA: No Excess Mortality Risk From Paclitaxel Stents, Balloons for Peripheral Intervention https://www.medscape.com/viewarticle/994253

    - FDA Statement https://www.fda.gov/medical-devices/letters-health-care-providers/update-paclitaxel-coated-devices-treat-peripheral-arterial-disease-unlikely-increase-risk-mortality?utm_medium=email&utm_source=govdelivery#_FDA_Actions

    III. Inclisiran

    FDA Expands Inclisiran Statin-Adjunct Indication to Include Primary Prevention https://www.medscape.com/viewarticle/994185

    - ORION 10-11 Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol https://www.nejm.org/doi/10.1056/NEJMoa1912387

    - Effect of inclisiran on lipids in primary prevention: the ORION-11 trial

    https://doi.org/10.1093/eurheartj/ehac615

    - Inclisiran and cardiovascular events: a patient-level analysis of phase III trials https://pubmed.ncbi.nlm.nih.gov/36331326/

    IV. DOAC Failure

    Association of Alternative Anticoagulation Strategies and Outcomes in Patients With Ischemic Stroke While Taking a Direct Oral Anticoagulant

    https://doi.org/10.1212/WNL.0000000000207422

    V. Primary or Secondary Prevention

    You may also like:

    Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

    https://www.medscape.com/features/public/machine

    The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

    https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Jul 7 2023 This Week in Cardiology Jul 07, 2023
    Show notes

    European HTN Guidelines, vitamin D, bempedoic acid, and leadless pacing, with some critical appraisal techniques thrown in, are the topics John Mandrola, MD, tackles in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I. European Hypertension Guidelines

    New ESH Hypertension Guidelines Aim for Simplified Message

    https://www.medscape.com/viewarticle/993913

    - 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH)

    https://pubmed.ncbi.nlm.nih.gov/37345492/

    II. Vitamin D

    CV Benefit From Vitamin-D Caps Hinted in Huge D-Health Trial

    https://www.medscape.com/viewarticle/993996

    - Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial

    https://www.bmj.com/content/381/bmj-2023-075230

    - Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials

    https://jamanetwork.com/journals/jamacardiology/fullarticle/2735646

    III. Bempedoic Acid

    'Striking' Benefit of Lipid Lowering in Primary Prevention

    https://www.medscape.com/viewarticle/993666

    - Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients

    https://jamanetwork.com/journals/jama/fullarticle/2806646

    - Bempedoic Acid for High-Risk Primary Prevention of Cardiovascular Disease

    https://jamanetwork.com/journals/jama/fullarticle/2806647

    - Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

    https://www.nejm.org/doi/full/10.1056/NEJMoa2215024

    IV. Leadless Pacing

    FDA Approves First Leadless Dual-Chamber Pacing System

    https://www.medscape.com/viewarticle/994033

    - A Dual-Chamber Leadless Pacemaker

    https://www.nejm.org/doi/full/10.1056/NEJMoa2300080

    You may also like:

    Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

    https://www.medscape.com/features/public/machine

    The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

    https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact

    news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Jun 23 2023 This Week in Cardiology Jun 23, 2023
    Show notes

    Starting HF meds during hospitalization for HF, Impella, testosterone, and colchicine are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I. Starting HF Meds During Hospitalization for HF

    Starting Indicated Heart Failure Meds In-Hospital: Progress, Opportunities https://www.medscape.com/viewarticle/993539

    - Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction https://www.jacc.org/doi/full/10.1016/j.jchf.2023.04.015

    II. Impella

    - Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock

    https://jamanetwork.com/journals/jamacardiology/fullarticle/2806562

    - Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart

    https://jamanetwork.com/journals/jamacardiology/fullarticle/2806565

    III. Testosterone

    Big Trial Reassures on Heart Safety of Testosterone in Men

    https://www.medscape.com/viewarticle/993322

    - Cardiovascular Safety of Testosterone-Replacement Therapy

    https://www.nejm.org/doi/full/10.1056/NEJMoa2215025

    IV. Colchicine for CV Disease

    Low-Dose Colchicine Approved for CVD: Now What?

    https://www.medscape.com/viewarticle/993578

    - Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

    https://www.nejm.org/doi/full/10.1056/nejmoa1912388

    - Colchicine in Patients with Chronic Coronary Disease

    https://www.nejm.org/doi/full/10.1056/nejmoa2021372

    You may also like:

    Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

    https://www.medscape.com/features/public/machine

    The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

    https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact

    news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    June 16 This Week in Cardiology Jun 16, 2023
    Show notes

    AF screening, BNP, a new SGLT2 inhibitor, a sky-is-blue study, and the UK Mini Mitral surgical trial are discussed in this week's podcast

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I AF Screening

    - Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.064361

    - Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial https://doi.org/10.1016/S0140-6736(21)01698-6

    - Natural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders https://www.jacc.org/doi/full/10.1016/j.jacc.2019.09.050

    - Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care https://jamanetwork.com/journals/jamacardiology/fullarticle/2801362

    - Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design https://doi.org/10.1093/europace/euw319

    - Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068511/

    II Frailty and GDMT of HFrEF

    Frailty Linked to Lower Use of Guideline Treatments in HFrEF

    https://www.medscape.com/viewarticle/993218

    - Physical Frailty and Use of Guideline‐Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction https://www.ahajournals.org/doi/10.1161/JAHA.122.026844

    III Sotagliflozin

    FDA Approves New Drug, Sotagliflozin, for Heart Failure

    https://www.medscape.com/viewarticle/992518

    - Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

    https://www.nejm.org/doi/full/10.1056/NEJMoa2030186

    - Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    https://www.nejm.org/doi/full/10.1056/NEJMoa2030183

    IV Mini-Mitral

    Support for Minimally Invasive Mitral Valve Repair: Mini Mitral Published

    https://www.medscape.com/viewarticle/993191

    - Minithoracotomy vs Conventional Sternotomy for Mitral Valve Repair

    https://jamanetwork.com/journals/jama/article-abstract/2805908

    You may also like:

    Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

    https://www.medscape.com/features/public/machine

    The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

    https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact: news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    June 9 This Week in Cardiology Jun 09, 2023
    Show notes

    Impella, digital health, low-value processes, are tricuspid valve interventions with pacing leads are the topics Dr. John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I. Impella Class I Recall

    FDA Class I Recall for Some Abiomed Impella Heart Pumps

    https://www.medscape.com/viewarticle/992845

    - A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention

    https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.112.098194

    - Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction

    https://doi.org/10.1016/j.jacc.2016.10.022

    https://www.sciencedirect.com/science/article/pii/S0735109716367675?via%3Dihub

    - The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support

    https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.119.044007

    - Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock

    https://jamanetwork.com/journals/jama/fullarticle/2761003

    - Danish Cardiogenic Shock Trial (DanShock)

    https://clinicaltrials.gov/ct2/show/NCT01633502

    II. Wearable Devices

    - Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2805753 doi:10.1001/jamanetworkopen.2023.16634

    - Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial

    https://doi.org/10.1016/S0140-6736(21)01698-6

    https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01698-6/fulltext

    - Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care

    https://jamanetwork.com/journals/jamacardiology/fullarticle/2801362

    III. The Cost of Quality Measures

    - The Volume and Cost of Quality Metric Reporting

    https://jamanetwork.com/journals/jama/fullarticle/2805705

    - Goodhart's law

    https://en.wikipedia.org/wiki/Goodhart%27s_law

    IV. Tricuspid Valve Interventions and Pacing Leads

    Leadless Dual-Chamber Pacemaker Clears Early Safety, Performance Hurdles

    https://www.medscape.com/viewarticle/992464

    - Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience

    https://www.jacc.org/doi/10.1016/j.jcin.2022.01.280

    - Effects of Implantable Cardioverter-Defibrillator Leads on the Tricuspid Valve and Right Ventricle: A Randomized Comparison of Transvenous versus Subcutaneous Leads

    https://eppro01.ativ.me/src/EventPilot/php/express/web/planner.php?id=HRS23&utm_source=heartrhythm&utm_medium=nav-button&utm_campaign=hr23-webtracking

    - Management and Outcomes of Transvenous Pacing Leads in Patients Undergoing Transcatheter Tricuspid Valve Replacement

    https://www.jacc.org/doi/10.1016/j.jcin.2020.04.054

    - TRILUMINATE trial -- Transcatheter Repair for Patients with Tricuspid Regurgitation

    https://www.nejm.org/doi/full/10.1056/NEJMoa2300525

    https://www.nejm.org/doi/full/10.1056/NEJMoa2300525

    You may also like:

    Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

    https://www.medscape.com/features/public/machine

    The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

    https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact

    news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Previous 1 14 15 16 17 18 43 Next

    Related Podcasts

    The Joe Rogan Experience

    1

    The Joe Rogan Experience Comedy
    More Perfect

    2

    More Perfect Government
    Casefile True Crime

    3

    Casefile True Crime Games & Hobbies
    Reply All

    4

    Reply All Games & Hobbies
    You Must Remember This

    5

    You Must Remember This Games & Hobbies
    Real Time with Bill Maher

    6

    Real Time with Bill Maher Games & Hobbies
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights